Back to Search

COLEMAN OBASAJU, MD

MD

Medical Oncology Physician

NPI: 1346515665Individual

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

01068323A(IN)

Research & Publications (20)

Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer.
PMID 19188545·Chest·2009
3-trial
Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
PMID 17043094·Ann Oncol·2007
3-trial
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
PMID 17092602·Lung Cancer·2007
8-other
Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedules.
PMID 16354316·Clin Lung Cancer·2005
3-trial
Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
PMID 19632943·Clin Lung Cancer·2009
3-trial
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
PMID 19364962·J Clin Oncol·2009
3-trial
Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial.
PMID 19150937·Ann Oncol·2009
3-trial
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS).
PMID 18781341·Support Care Cancer·2009
8-other
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
PMID 19075278·J Clin Oncol·2009
3-trial
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
PMID 18166839·J Thorac Oncol·2008
3-trial
Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
PMID 18978567·J Thorac Oncol·2008
3-trial
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.
PMID 18827606·J Thorac Oncol·2008
3-trial
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
PMID 18640937·J Clin Oncol·2008
3-trial
Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.
PMID 18379358·J Thorac Oncol·2008
3-trial
Efficacy and safety of pemetrexed in elderly cancer patients: results of an integrated analysis.
PMID 18358737·Crit Rev Oncol Hematol·2008
8-other
Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
PMID 18349397·J Clin Oncol·2008
3-trial
Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program.
PMID 17409909·J Thorac Oncol·2006
3-trial
A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
PMID 17409822·J Thorac Oncol·2006
3-trial
Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer.
PMID 17050869·J Clin Oncol·2006
3-trial
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.
PMID 16849761·J Clin Oncol·2006
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
12098 ASHCROFT PL
CARMEL, IN 46032

Location

Practice Location

12098 ASHCROFT PL, CARMEL, IN
(317) 727-4391

Quick Facts

NPI
1346515665
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile